120 related articles for article (PubMed ID: 2155475)
1. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
Oosterlaken TA; Harmsen M; Kraaijeveld CA; Snippe H
Scand J Immunol; 1990 Feb; 31(2):159-65. PubMed ID: 2155475
[TBL] [Abstract][Full Text] [Related]
2. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
[TBL] [Abstract][Full Text] [Related]
3. Efficient induction of Semliki Forest virus and mumps virus neutralizing anti-anti-idiotypic antibodies using Quil A as adjuvant.
Oosterlaken TA; Brandenburg A; Schielen P; Fransen R; Kraaijeveld CA; Snippe H
J Immunol Methods; 1991 Feb; 136(2):169-75. PubMed ID: 1999649
[TBL] [Abstract][Full Text] [Related]
4. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
5. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
Oosterlaken TA; Harmsen M; Tangerman C; Schielen P; Kraaijeveld CA; Snippe H
J Immunol Methods; 1988 Dec; 115(2):255-61. PubMed ID: 3058808
[TBL] [Abstract][Full Text] [Related]
6. IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.
Oosterlaken TA; Harmsen M; Ekstijn GL; Kraaijeveld CA; Snippe H
Immunology; 1992 Feb; 75(2):224-31. PubMed ID: 1551685
[TBL] [Abstract][Full Text] [Related]
7. Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.
Harmsen M; Oosterlaken TA; Tangerman C; Snippe H; Kraaijeveld CA
J Virol Methods; 1993 Jul; 43(2):137-46. PubMed ID: 8396153
[TBL] [Abstract][Full Text] [Related]
8. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
[TBL] [Abstract][Full Text] [Related]
9. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
Fernández IM; Snijders A; Benaissa-Trouw BJ; Harmsen M; Snippe H; Kraaijeveld CA
J Virol; 1993 Oct; 67(10):5843-8. PubMed ID: 7690411
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
J Virol; 1985 May; 54(2):546-51. PubMed ID: 2985817
[TBL] [Abstract][Full Text] [Related]
11. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Boere WA; Kraaijeveld CA; Snippe H
Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
[No Abstract] [Full Text] [Related]
12. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H
J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
[TBL] [Abstract][Full Text] [Related]
13. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A
J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217
[TBL] [Abstract][Full Text] [Related]
14. Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease.
Vlaspolder F; Oosterlaken TA; Harmsen M; van Dijk PW; Kievit H; Kraaijeveld CA; Snippe H
Arch Virol; 1990; 110(3-4):277-85. PubMed ID: 2156488
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies.
Oosterlaken TA; Kraaijeveld CA; Snijders A; Harmsen M; Benaissa-Trouw BJ; Snippe H
Arch Virol; 1988; 100(1-2):115-20. PubMed ID: 2455492
[TBL] [Abstract][Full Text] [Related]
16. A shared idiotope among antibodies against Semliki Forest virus.
Fernández IM; Ovaa W; Harmsen M; Benaissa-Trouw BJ; Bos NA; Kraaijeveld CA; Snippe H
Viral Immunol; 1994; 7(2):71-80. PubMed ID: 7531444
[TBL] [Abstract][Full Text] [Related]
17. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
Barrett AD; Dimmock NJ
Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
[TBL] [Abstract][Full Text] [Related]
18. Homology of ab1 and ab3 monoclonal antibodies that neutralize Semliki Forest virus.
Fernández IM; Bos NA; Harmsen M; Verheul AF; Snippe H; Kraaijeveld CA
Viral Immunol; 2001; 14(2):119-24. PubMed ID: 11398807
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.
Stanton GJ; Lloyd RE; Sarzotti M; Blalock JE
Mol Biother; 1989; 1(6):305-10. PubMed ID: 2558683
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
Barrett AD; Dimmock NJ
J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
